Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
    • Topics A-Z
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

February 2018; 4 (1) Clinical/Scientific NotesOpen Access

Novel hemizygous nonsense mutation in DRP2 is associated with inherited neuropathy

Ricardo H. Roda, Brett A. McCray, Christopher J. Klein, Ahmet Hoke
First published January 24, 2018, DOI: https://doi.org/10.1212/NXG.0000000000000220
Ricardo H. Roda
From the Department of Neurology (R.H.R., B.A.M., A.H.), Johns Hopkins University School of Medicine, Baltimore, MD; and Department of Neurology (C.J.K.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett A. McCray
From the Department of Neurology (R.H.R., B.A.M., A.H.), Johns Hopkins University School of Medicine, Baltimore, MD; and Department of Neurology (C.J.K.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher J. Klein
From the Department of Neurology (R.H.R., B.A.M., A.H.), Johns Hopkins University School of Medicine, Baltimore, MD; and Department of Neurology (C.J.K.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmet Hoke
From the Department of Neurology (R.H.R., B.A.M., A.H.), Johns Hopkins University School of Medicine, Baltimore, MD; and Department of Neurology (C.J.K.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Novel hemizygous nonsense mutation in DRP2 is associated with inherited neuropathy
Ricardo H. Roda, Brett A. McCray, Christopher J. Klein, Ahmet Hoke
Neurol Genet Feb 2018, 4 (1) e220; DOI: 10.1212/NXG.0000000000000220

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
528

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Mutations in DRP2 (OMIM #300052) encoding dystrophin-related protein 2, a 957 amino acid protein, were identified in a single patient with X-linked Charcot-Marie-Tooth (CMT) disease and are associated with familial autism.1,2 DRP2 is predominantly expressed in the brain and spinal cord and functionally interacts with periaxin (PRX, OMIM #605725), a known causative CMT gene (OMIM #614895 and #145900), in the PRX-DRP2-dystroglycan (PDG) complex.3 The PDG complex supports and maintains Cajal bands, which are cytoplasmic extensions that run along the length of myelinated axons and are required for establishing a proper internodal length.4,–,6

A nonsense DRP2 c.805C>T (Q269X) mutation was found in a patient with sensorimotor neuropathy, with intermediate conduction velocities and absence of Cajal bands within dermal nerves.1 Here, we report another patient with a novel nonsense mutation in DRP2 with sensorimotor polyneuropathy and histologic myelin abnormalities. This report extends the known mutation spectrum of DRP2 and provides further evidence of its association with inherited neuropathy.

Case report

The index patient is a 42-year-old man who developed fatigue, numbness and tingling in his fingers and toes, and headaches at the age of 18. Over time, he developed patchy burning in his extremities, intermittent numbness in his face, heat intolerance, and excessive sweating. There was no family history of neuropathy. Nerve conduction studies at the age of 33 demonstrated mildly slowed conduction velocities and prolonged F-wave latencies in the lower extremities. A left sural nerve biopsy showed fibers with tomaculae, thinly myelinated fibers, and a small focus of perivascular epineurial inflammation. A lumbar puncture was performed and showed normal CSF protein levels and cell counts. Testing for diabetes mellitus, Sjogren syndrome, HIV, and Lyme disease was negative, and hexosaminidase A and α-galactosidase levels were normal. Testing for mutations of PMP22, MFN2, and GBJ1 was negative.

At the age of 40, examination showed normal cognition, cranial nerves, muscle bulk, tone, and strength. He was able to walk on his heels and toes. Deep tendon reflexes were mildly reduced at the ankles (1+) but were otherwise normal. There was multimodal distal sensory loss with light touch, pinprick, and temperature reduced in the lower extremities to the mid-shins and in the upper extremities to the mid-forearms. Joint position sense was preserved, and vibration sense was normal except for a mild reduction at the left first toe. Augmented Romberg (feet in tandem position) was positive. Repeat electrophysiology revealed evidence of lower extremity demyelinating neuropathy with nonuniformly reduced conduction velocities of the bilateral peroneal motor nerves (right 31 m/s, left 22 m/s, normal ≥40 m/s) with normal distal latencies, partial motor conduction block in the bilateral peroneal motor nerves recorded at the extensor digitorum brevis muscle ([ankle vs fibular head stimulation]: right [2.5 vs 0.9 mV], left [1.5 vs 0.1 mV]), and markedly prolonged lower extremity F-wave latencies (right tibial 82 milliseconds, left peroneal 73 milliseconds, normal <56 milliseconds). Upper extremity testing showed a normal conduction velocity in the median motor nerve and a slightly reduced velocity (46 m/s, normal ≥50 m/s) in the ulnar motor nerve. Skin biopsy and autonomic testing were normal.

Electron microscopy of his sural nerve revealed a mild reduction in the density of large myelinated and unmyelinated axons as well as prominent variability in myelin thickness with many thinly myelinated fibers and some abnormally thick myelinated fibers (figure). We observed many fibers with delamination of myelin, occasional Cajal bands, rare tomaculae, rare active demyelination, and rare miniature onion bulbs indicative of prior demyelination and attempted remyelination. Whole-exome sequencing revealed a hemizygous c.1039C>T, p.Q347X variant in DRP2 that creates a premature stop codon. This variant is not present in the database of the Exome Aggregation Consortium (exac.broadinstitute.org, September 2016). His unaffected mother is a carrier for the change.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Sural nerve electron microscopy

(A and B) Sural nerve biopsy shows variability in myelin thickness, with some fibers exhibiting thicker myelin sheets relative to axon diameter (thin arrows) and many others harboring thin myelin (thick arrowheads). Many of the thicker myelinated fibers showed delamination. (C and D) Higher power view of myelin thickness variability. Thickly myelinated axon (thin arrow) shows a small tomacula. (E) Miniature onion bulb formation. (F) A myelinated axon (thin arrow) undergoing demyelination. Scale bars denote 10 μm in A and B, 5 μm in C and D, and 2 μm in E and F.

Discussion

In this report, we present a patient with early adult-onset sensorimotor neuropathy with biopsy-proven myelination abnormalities and a likely pathogenic hemizygous mutation in the X-linked gene DRP2. This mutation produces a premature stop codon and is expected to lead to a loss of functional protein and likely a complete absence of DRP2 in men.1,7 The biopsy findings are reminiscent of the previously reported patient with DRP2 mutation who displayed the absence of Cajal bands in dermal nerves, and to the histologic features of Drp2-null mice, which show disrupted appositions of Cajal bands, focal hypermyelination, demyelination, and tomacula-like formations.1,8 Similarly, Prx-null mice also show the absence of Cajal bands, shortened internodal length, and reduced conduction velocities.9 It is important that the patient reported here had features of both developmental dysmyelination as well as nonuniform demyelination, the latter of which was not present in the previously reported patient with DRP2 mutation. This report provides further evidence linking truncating DRP2 mutations with demyelinating neuropathy and suggests that DRP2 variants should be considered when evaluating patients suspected of inherited neuropathy.

Author contributions

Dr. Roda: drafting and revision of the manuscript and analysis of patient data. Dr. McCray: critical analysis and revision of the manuscript. Dr. Klein: patient care and critical analysis and revision of the manuscript. Dr. Hoke: patient care, electron microscopy, and critical analysis and revision of the manuscript.

Study funding

No targeted funding reported.

Disclosure

R. Roda and McCray have received research support from the NIH. B. C. Klein serves on the CMTA Research and Therapeutics board (a nonprofit patient support group); serves on the editorial board of Neurology®; and receives research support from a Mayo Clinic research grant. Dr. Hoke serves on the scientific advisory board of the Foundation for Peripheral Neuropathy; serves on the editorial boards of Experimental Neurology and Annals of Clinical Translational Neurology; holds patents for Use of ethoxyquin to prevent neuropathy and for Electro-spun fiber mesh to help nerve regeneration; is an employee of Johns Hopkins University; has served as a consultant for Neurocrine Inc.; has received research support from the NIH, the Foundation for Peripheral Neuropathy, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; gave expert testimony on GBS for National Vaccine Injury Program, and gave expert testimony on peripheral neuropathy for Arnold & Porter Kaye Scholer LLP. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

  • The Article Processing Charge was funded by the authors.

  • Received August 8, 2017.
  • Accepted in final form December 12, 2017.
  • Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Brennan KM,
    2. Bai Y,
    3. Pisciotta C, et al
    . Absence of dystrophin related protein-2 disrupts Cajal bands in a patient with Charcot-Marie-Tooth disease. Neuromuscul Disord 2015;25:786–793.
    OpenUrl
  2. 2.↵
    1. Toma C,
    2. Torrico B,
    3. Hervas A, et al
    . Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol Psychiatry 2014;19:784–790.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Roberts RG,
    2. Freeman TC,
    3. Kendall E, et al
    . Characterization of DRP2, a novel human dystrophin homologue. Nat Genet 1996;13:223–226.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Guilbot A,
    2. Williams A,
    3. Ravise N, et al
    . A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001;10:415–421.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Court FA,
    2. Sherman DL,
    3. Pratt T, et al
    . Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 2004;431:191–195.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Sherman DL,
    2. Fabrizi C,
    3. Gillespie CS,
    4. Brophy PJ
    . Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 2001;30:677–687.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Inoue K,
    2. Khajavi M,
    3. Ohyama T, et al
    . Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 2004;36:361–369.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Sherman DL,
    2. Wu LM,
    3. Grove M,
    4. Gillespie CS,
    5. Brophy PJ
    . Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J Neurosci 2012;32:9419–9428.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Gillespie CS,
    2. Sherman DL,
    3. Fleetwood-Walker SM, et al
    . Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 2000;26:523–531.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case report
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Peripheral neuropathy

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Brief Communications
    Segmental conduction abnormalities and myelin thickenings in Val102/fs null mutation of MPZ gene
    M. V. De Angelis, A. Di Muzio, M. Capasso et al.
    Neurology, December 13, 2004
  • Articles
    Mutations in GDAP1
    Autosomal recessive CMT with demyelination and axonopathy
    E. Nelis, S. Erdem, P. Y.K. Van den Bergh et al.
    Neurology, December 24, 2002
  • Articles
    Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B
    A. Sabet, J. Li, K. Ghandour et al.
    Neurology, October 09, 2006
  • Article
    Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies
    Claire G. Salter, Danique Beijer, Holly Hardy et al.
    Neurology: Genetics, March 23, 2018
Neurology Genetics: 9 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise